Dopaminergic neurons--alteration in the kinetic properties of tyrosine hydroxylase after cessation of impulse flow.
D015107:4-Butyrolactone / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D003342:Corpus Striatum / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000502:physiology*; D004533:Egtazic Acid / Q000494:pharmacology; D005260:Female; D007700:Kinetics; D008297:Male; D008473:Median Eminence / Q000201:enzymology; D009474:Neurons / Q000502:physiology*; D009830:Olfactory Bulb / Q000201:enzymology; D010879:Piperazines / Q000494:pharmacology; D011622:Pterins / Q000378:metabolism; D051381:Rats; D011941:Receptors, Adrenergic / Q000187:drug effects; D013378:Substantia Nigra / Q000502:physiology; D013569:Synapses / Q000502:physiology; D009435:Synaptic Transmission; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors / Q000378:metabolism*
D010879:Piperazines; D011622:Pterins; D011941:Receptors, Adrenergic; D004533:Egtazic Acid; D004295:Dihydroxyphenylalanine; D014446:Tyrosine 3-Monooxygenase; D001058:Apomorphine; D015107:4-Butyrolactone; D002118:Calcium; D004298:Dopamine